Allan Wailoo

University of Sheffield

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (15)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (9)

Ivonne Solis-Trapala

Keele CTU Director and Reader in Biostatistics

Kiel University

UNITED KINGDOM

View details

Harry Hill

University of Sheffield

UNITED KINGDOM

View details

Manuel Gomes

Senior Lecturer

University College London

UNITED KINGDOM

View details

Matthew Bursnall

University of Sheffield

UNITED KINGDOM

View details

Simon Davies

Professor of Nephrology and Dialysis Medicine

Keele University

UNITED KINGDOM

View details

Donna Rowen

Professor of Health Economics

University of Sheffield

UNITED KINGDOM

View details

Laura Gray

University of Sheffield

UNITED KINGDOM

View details

Stephen Pudney

University of Sheffield

UNITED KINGDOM

View details

Andrew Metry

University of Sheffield

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Allan Wailoo

Research Interests

Explore related searches

Contact this professor

Articles (15)

The clinical implications and cost-effectiveness of the provision of medical in addition to surgical catheter insertion for peritoneal dialysis in people with kidney failure

The Cost-Effectiveness of Initiating Patients on Home Dialysis Compared with In-Centre Haemodialysis

EQ health and wellbeing (EQ-HWB): a psychometric assessment across six conditions and the general population in the United Kingdom

Mapping EQ-5D-5L Utilities in Dementia: Integrating Self and Proxy Reports

Exploring the factors that drive clinical negligence claims: stated preferences of those who have experienced unintended harm

Does EQ-5D Tell the whole story? Statistical methods for comparing the thematic coverage of clinical and generic outcome measures, with application to breast cancer

Estimating the relationship between EQ-5D-5L and EQ-5D-3L: results from a UK population study

Protocol for the ORION trial (RadiO fRequency ablatION for haemorrhoids): a randomised controlled trial

Target Trial Emulation for Transparent and Robust Estimation of Treatment Effects for Health Technology Assessment Using Real-World Data: Opportunities and Challenges

A cost-effectiveness analysis of remdesivir for the treatment of hospitalised patients with COVID-19 in England and Wales

Assessing the psychometric performance of EQ-5D-5L in dementia : a systematic review

Convergent validity of EQ-5D with core outcomes in dementia: a systematic review

Correction to: Mapping the EORTC QLQ-C30 to EQ-5D-3L in patients with breast cancer

Should we consider including a value for "Hope" as an additional benefit within health technology assessment?

A discrete choice experiment to elicit general population preferences around the factors influencing the choice to make clinical negligence claims

Collaborators (9)

Ivonne Solis-Trapala

Harry Hill

Manuel Gomes

Matthew Bursnall

Simon Davies

Donna Rowen

Laura Gray

Stephen Pudney

Andrew Metry

Make your next move.